“Can Do” Versus “Do Do” in Patients with Asthma at First Referral to a Pulmonologist

Do We Know What We Do not Know? A Response to Celine Bonnet

Performance of electrophysiologic study in an asymptomatic patient with type 2 intermittent Brugada syndrome: To do or not to do?

Background: Brugada syndrome (BrS) is an inherited channelopathy, which is associated with sudden cardiac death due to rapid polymorphic VT or VF. There is no definite consensus regarding the management of asymptomatic patients. Some experts advocate close follow-up; others propose the programmed stimulation for risk stratification. We aimed to evaluate the benefit of complete atrial and ventri...

tube thoracostomy (chest tube) removal in traumatic patients: what do we know? what can we do?

chest tube (ct) or tube thoracostomy placement is often indicated following traumatic injuries. premature movement of the chest tube leads to increased hospital complications and costs for patients. placement of a chest tube is indicated in drainage of blood, bile, pus, drain air, and other fluids. although there is a general agreement for the placement of a chest tube, there is little consensu...

Travel Diarrhea in Childhood “First Part; what do we know?”

Can we do something in early life to reduce the risk of obesity?

Obesity usually results from a combination of several modifiable and non-modifiable contributing factors, such as genetics, race, and socioeconomic status. Other factors, including birth by cesarean section, perinatal antibiotics usage, and promotion of exclusive breastfeeding for six months, could be potentially prevented or modulated. However, one of the factors can be easily implemented thro...